Loading
Loading
Cognitive & Nootropic · 50mg
Choose dose
Janoshik-tested · 10 vials per kit
NA-Selank is an intranasal-optimised variant of Selank studied in preclinical and clinical research for its anxiolytic and nootropic properties. Research has examined its potential to alleviate anxiety, regulate emotional balance, reduce depressive symptoms, and improve memory and attention, with enhanced bioavailability via nasal delivery compared to standard peptide routes.
≥98%
Purity
Lyophilised
Format
2–3 wks
Arrival
Don't want to wait 3 weeks?
Check local stock — weekday same/next-day delivery available.
Need to work out your dose?
Use our reconstitution calculator — syringe units in seconds.
Research Use Only — Disclaimer
This product is intended solely as a research chemical for laboratory and scientific study purposes only. It is not approved by the TGA or any regulatory body for human or animal consumption, therapeutic use, or clinical application. The information provided on this website is for educational purposes only. Handling must be limited to suitably qualified professionals operating within applicable laws and regulations. This product is not classified as a drug, food, cosmetic, or medicinal product and must not be used or labelled as such. By purchasing, you confirm you are a qualified research professional and accept full responsibility for compliance with all relevant laws in your jurisdiction.
Selank
Selank (TP-7) is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from the endogenous tetrapeptide tuftsin, with a Pro-Gly-Pro extension for metabolic stability. Developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, it is approved in Russia as an anxiolytic medication. Its profile is distinct from classical anxiolytics — it shows anxiolytic activity without sedation, dependence, or withdrawal effects in reported studies.
Selank's anxiolytic effects involve modulation of the GABA-A receptor system, although it does not bind directly to the benzodiazepine site. It also inhibits enkephalinase activity — the enzyme responsible for degrading endogenous enkephalins — effectively extending their anxiolytic duration. Selank upregulates BDNF expression in hippocampal tissue and modulates IL-6 and other cytokines, linking its nootropic and immunomodulatory properties.
Russian-language clinical studies describe Selank's efficacy in generalised anxiety disorder, phobic disorder, and asthenic conditions. Nootropic applications studied include working memory improvement and stress-resilience enhancement. Immune-modulating properties have been investigated in models of viral infection and immune deficiency states. NA-Selank (N-acetyl Selank) is a variant with modified N-terminal acylation studied for enhanced nasal bioavailability.
Key References
For research reference only. All information pertains to preclinical or published human trial data. Not intended as medical advice. This product is for research use only.
Don't have supplies? Grab them while you're here.
